MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer

ConclusionsOur results imply that MHY4571 may be a potential drug candidate for squamous cell lung cancer treatment.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research